Similar articles

• The effect of propranolol on the serum lipids in diabetics with coronary heart disease.

  Safwat HM, Sharawy M, El Safouri S. Safwat HM, et al. J Egypt Med Assoc. 1978;61(9-10):577-83. J Egypt Med Assoc. 1978. PMID: 262244 No abstract available.
• [Plasma lipid and lipoprotein content in chronic ischemic heart disease depending on patients' personality trends].

  Bel'chenko DI, Lazarev VI. Bel'chenko DI, et al. Ter Arkh. 1982;54(10):55-7. Ter Arkh. 1982. PMID: 7179121 Russian. No abstract available.
• [Lipid metabolism in patients with ischemic heart disease--with particular reference to serum free fatty acid response to sympathico-adrenomedullary activity].

  Ashie T. Ashie T. Sapporo Igaku Zasshi. 1969 Mar;35(3):161-73. Sapporo Igaku Zasshi. 1969. PMID: 5392361 Japanese. No abstract available.
• [Lipid composition of mononuclear and polymorphonuclear leukocytes from peripheral blood of patients with chronic ischemic heart disease].

  Zhukhorov LS. Zhukhorov LS. Vopr Med Khim. 1983 Mar-Apr;29(2):11-3. Vopr Med Khim. 1983. PMID: 6858027 Russian.
• [Influence of physical activity on plasma levels of lipids and lipoproteins in patients with coronary disease].

  Da Silva MJ, Netto MP, Kedor HH, Camargo PA, Kiss MA, Giannini SD, Deperon SD. Da Silva MJ, et al. Arq Bras Cardiol. 1988 Apr;50(4):231-6. Arq Bras Cardiol. 1988. PMID: 3067692 Review. Portuguese. No abstract available.